EUROPEAN JOURNAL OF PHARMACOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2234202, encodeId=87a3223420201, content=9.14 投稿 9.16外审3个审稿人（之前投过主编说按之前3个审稿人意见修改后再投）当天一个审回 10.5另外一个审回还有一个未接收 review completed 10.6 dip 到今天还是dip 不知什么情况有类似这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04fe5219567, createdName=14778916m81暂无昵称, createdTime=Wed Oct 30 23:33:24 CST 2024, time=2024-10-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2271770, encodeId=968c22e177037, content=状态显示tranfer pending是拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9f9768309, createdName=ms1000001928455201, createdTime=Wed Jul 02 19:42:25 CST 2025, time=2025-07-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2271108, encodeId=8a0d22e1108b8, content=投稿系统中要求通讯作者必须提供机构邮箱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Jun 27 14:56:46 CST 2025, time=2025-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2271107, encodeId=ff5e22e110735, content=提供系统中要求通讯作者必须提供机构邮箱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Jun 27 14:56:31 CST 2025, time=2025-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2266799, encodeId=94f92266e99a9, content=审稿速度:3.0 经验分享：审稿建议里面让找更专业的英语编辑，并提供了语言修饰的网址，我需要花钱修饰语言吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce5a2105858, createdName=心血管敏, createdTime=Tue May 27 08:25:11 CST 2025, time=2025-05-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2254478, encodeId=1f0022544e8a7, content=审稿速度:2.0 偏重的研究方向：心血管病 经验分享：二审后dip2周了，接心软编辑，hope, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9oU11do4KdicQ5zeAeucWoJskC9juemF0Skj0W2iauBhSRLRySPPAib72KGiagGT3XXeyeQKlibUJMDBQXykJOngT7A/132, createdBy=1aaf5315474, createdName=Tilen, createdTime=Tue Mar 04 00:30:39 CST 2025, time=2025-03-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2221998, encodeId=85ac2221998e7, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肾脏;药理学 经验分享：5月17日提交，5月20日编辑要求提交WB三次重复结果，当天提交，过了一周送审，6月11日一审结束，两个审稿人提了很多问题，7月15日一审修改返回，7月17日二审开始，7月26日二审结束，一个审稿人要求补实验否则拒收，另外一个审稿人表示没有问题，8月7日二审补实验修改返回，8月9日三审开始，8月15日三审结束，8月16日DIP，8月22日接收，祝各位好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202408/eb5b5a9ed51e4ee5806df9de0f938634-HFNTLBQQrRUU.jpg, createdBy=42278230289, createdName=研究牲小F, createdTime=Fri Aug 23 01:24:08 CST 2024, time=2024-08-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2246816, encodeId=4d9e224681683, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：药理学;炎症 经验分享：求问大家这个杂志编辑什么时候上班啊，我10月底投的稿，11.01送审，一审还没回来，等到花儿都谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b26e8424498, createdName=ms9000000976333684, createdTime=Mon Jan 06 11:29:42 CST 2025, time=2025-01-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2261842, encodeId=607c226184268, content=审稿人接受了邀请但迟迟不审稿该怎么办，已经一个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded55595736, createdName=ms4000000082043336, createdTime=Thu Apr 24 12:15:10 CST 2025, time=2025-04-24, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2264698, encodeId=6d1a226469848, content=4月29号提交, 5月12号under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2e26491969, createdName=ms8000000177380007, createdTime=Mon May 12 19:24:02 CST 2025, time=2025-05-12, status=1, ipAttribution=上海)]

2024-10-30 14778916m81暂无昵称来自北京

9.14 投稿 9.16外审3个审稿人（之前投过主编说按之前3个审稿人意见修改后再投）当天一个审回 10.5另外一个审回还有一个未接收 review completed 10.6 dip 到今天还是dip 不知什么情况有类似这种情况吗

38 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2234202, encodeId=87a3223420201, content=9.14 投稿 9.16外审3个审稿人（之前投过主编说按之前3个审稿人意见修改后再投）当天一个审回 10.5另外一个审回还有一个未接收 review completed 10.6 dip 到今天还是dip 不知什么情况有类似这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04fe5219567, createdName=14778916m81暂无昵称, createdTime=Wed Oct 30 23:33:24 CST 2024, time=2024-10-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2271770, encodeId=968c22e177037, content=状态显示tranfer pending是拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9f9768309, createdName=ms1000001928455201, createdTime=Wed Jul 02 19:42:25 CST 2025, time=2025-07-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2271108, encodeId=8a0d22e1108b8, content=投稿系统中要求通讯作者必须提供机构邮箱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Jun 27 14:56:46 CST 2025, time=2025-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2271107, encodeId=ff5e22e110735, content=提供系统中要求通讯作者必须提供机构邮箱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Jun 27 14:56:31 CST 2025, time=2025-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2266799, encodeId=94f92266e99a9, content=审稿速度:3.0 经验分享：审稿建议里面让找更专业的英语编辑，并提供了语言修饰的网址，我需要花钱修饰语言吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce5a2105858, createdName=心血管敏, createdTime=Tue May 27 08:25:11 CST 2025, time=2025-05-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2254478, encodeId=1f0022544e8a7, content=审稿速度:2.0 偏重的研究方向：心血管病 经验分享：二审后dip2周了，接心软编辑，hope, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9oU11do4KdicQ5zeAeucWoJskC9juemF0Skj0W2iauBhSRLRySPPAib72KGiagGT3XXeyeQKlibUJMDBQXykJOngT7A/132, createdBy=1aaf5315474, createdName=Tilen, createdTime=Tue Mar 04 00:30:39 CST 2025, time=2025-03-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2221998, encodeId=85ac2221998e7, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肾脏;药理学 经验分享：5月17日提交，5月20日编辑要求提交WB三次重复结果，当天提交，过了一周送审，6月11日一审结束，两个审稿人提了很多问题，7月15日一审修改返回，7月17日二审开始，7月26日二审结束，一个审稿人要求补实验否则拒收，另外一个审稿人表示没有问题，8月7日二审补实验修改返回，8月9日三审开始，8月15日三审结束，8月16日DIP，8月22日接收，祝各位好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202408/eb5b5a9ed51e4ee5806df9de0f938634-HFNTLBQQrRUU.jpg, createdBy=42278230289, createdName=研究牲小F, createdTime=Fri Aug 23 01:24:08 CST 2024, time=2024-08-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2246816, encodeId=4d9e224681683, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：药理学;炎症 经验分享：求问大家这个杂志编辑什么时候上班啊，我10月底投的稿，11.01送审，一审还没回来，等到花儿都谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b26e8424498, createdName=ms9000000976333684, createdTime=Mon Jan 06 11:29:42 CST 2025, time=2025-01-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2261842, encodeId=607c226184268, content=审稿人接受了邀请但迟迟不审稿该怎么办，已经一个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded55595736, createdName=ms4000000082043336, createdTime=Thu Apr 24 12:15:10 CST 2025, time=2025-04-24, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2264698, encodeId=6d1a226469848, content=4月29号提交, 5月12号under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2e26491969, createdName=ms8000000177380007, createdTime=Mon May 12 19:24:02 CST 2025, time=2025-05-12, status=1, ipAttribution=上海)]

2025-07-02 ms1000001928455201 来自上海

状态显示tranfer pending是拒稿了吗

4 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2234202, encodeId=87a3223420201, content=9.14 投稿 9.16外审3个审稿人（之前投过主编说按之前3个审稿人意见修改后再投）当天一个审回 10.5另外一个审回还有一个未接收 review completed 10.6 dip 到今天还是dip 不知什么情况有类似这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04fe5219567, createdName=14778916m81暂无昵称, createdTime=Wed Oct 30 23:33:24 CST 2024, time=2024-10-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2271770, encodeId=968c22e177037, content=状态显示tranfer pending是拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9f9768309, createdName=ms1000001928455201, createdTime=Wed Jul 02 19:42:25 CST 2025, time=2025-07-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2271108, encodeId=8a0d22e1108b8, content=投稿系统中要求通讯作者必须提供机构邮箱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Jun 27 14:56:46 CST 2025, time=2025-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2271107, encodeId=ff5e22e110735, content=提供系统中要求通讯作者必须提供机构邮箱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Jun 27 14:56:31 CST 2025, time=2025-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2266799, encodeId=94f92266e99a9, content=审稿速度:3.0 经验分享：审稿建议里面让找更专业的英语编辑，并提供了语言修饰的网址，我需要花钱修饰语言吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce5a2105858, createdName=心血管敏, createdTime=Tue May 27 08:25:11 CST 2025, time=2025-05-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2254478, encodeId=1f0022544e8a7, content=审稿速度:2.0 偏重的研究方向：心血管病 经验分享：二审后dip2周了，接心软编辑，hope, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9oU11do4KdicQ5zeAeucWoJskC9juemF0Skj0W2iauBhSRLRySPPAib72KGiagGT3XXeyeQKlibUJMDBQXykJOngT7A/132, createdBy=1aaf5315474, createdName=Tilen, createdTime=Tue Mar 04 00:30:39 CST 2025, time=2025-03-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2221998, encodeId=85ac2221998e7, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肾脏;药理学 经验分享：5月17日提交，5月20日编辑要求提交WB三次重复结果，当天提交，过了一周送审，6月11日一审结束，两个审稿人提了很多问题，7月15日一审修改返回，7月17日二审开始，7月26日二审结束，一个审稿人要求补实验否则拒收，另外一个审稿人表示没有问题，8月7日二审补实验修改返回，8月9日三审开始，8月15日三审结束，8月16日DIP，8月22日接收，祝各位好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202408/eb5b5a9ed51e4ee5806df9de0f938634-HFNTLBQQrRUU.jpg, createdBy=42278230289, createdName=研究牲小F, createdTime=Fri Aug 23 01:24:08 CST 2024, time=2024-08-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2246816, encodeId=4d9e224681683, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：药理学;炎症 经验分享：求问大家这个杂志编辑什么时候上班啊，我10月底投的稿，11.01送审，一审还没回来，等到花儿都谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b26e8424498, createdName=ms9000000976333684, createdTime=Mon Jan 06 11:29:42 CST 2025, time=2025-01-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2261842, encodeId=607c226184268, content=审稿人接受了邀请但迟迟不审稿该怎么办，已经一个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded55595736, createdName=ms4000000082043336, createdTime=Thu Apr 24 12:15:10 CST 2025, time=2025-04-24, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2264698, encodeId=6d1a226469848, content=4月29号提交, 5月12号under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2e26491969, createdName=ms8000000177380007, createdTime=Mon May 12 19:24:02 CST 2025, time=2025-05-12, status=1, ipAttribution=上海)]

2025-06-27 匿名用户

投稿系统中要求通讯作者必须提供机构邮箱

7 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2234202, encodeId=87a3223420201, content=9.14 投稿 9.16外审3个审稿人（之前投过主编说按之前3个审稿人意见修改后再投）当天一个审回 10.5另外一个审回还有一个未接收 review completed 10.6 dip 到今天还是dip 不知什么情况有类似这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04fe5219567, createdName=14778916m81暂无昵称, createdTime=Wed Oct 30 23:33:24 CST 2024, time=2024-10-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2271770, encodeId=968c22e177037, content=状态显示tranfer pending是拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9f9768309, createdName=ms1000001928455201, createdTime=Wed Jul 02 19:42:25 CST 2025, time=2025-07-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2271108, encodeId=8a0d22e1108b8, content=投稿系统中要求通讯作者必须提供机构邮箱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Jun 27 14:56:46 CST 2025, time=2025-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2271107, encodeId=ff5e22e110735, content=提供系统中要求通讯作者必须提供机构邮箱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Jun 27 14:56:31 CST 2025, time=2025-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2266799, encodeId=94f92266e99a9, content=审稿速度:3.0 经验分享：审稿建议里面让找更专业的英语编辑，并提供了语言修饰的网址，我需要花钱修饰语言吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce5a2105858, createdName=心血管敏, createdTime=Tue May 27 08:25:11 CST 2025, time=2025-05-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2254478, encodeId=1f0022544e8a7, content=审稿速度:2.0 偏重的研究方向：心血管病 经验分享：二审后dip2周了，接心软编辑，hope, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9oU11do4KdicQ5zeAeucWoJskC9juemF0Skj0W2iauBhSRLRySPPAib72KGiagGT3XXeyeQKlibUJMDBQXykJOngT7A/132, createdBy=1aaf5315474, createdName=Tilen, createdTime=Tue Mar 04 00:30:39 CST 2025, time=2025-03-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2221998, encodeId=85ac2221998e7, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肾脏;药理学 经验分享：5月17日提交，5月20日编辑要求提交WB三次重复结果，当天提交，过了一周送审，6月11日一审结束，两个审稿人提了很多问题，7月15日一审修改返回，7月17日二审开始，7月26日二审结束，一个审稿人要求补实验否则拒收，另外一个审稿人表示没有问题，8月7日二审补实验修改返回，8月9日三审开始，8月15日三审结束，8月16日DIP，8月22日接收，祝各位好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202408/eb5b5a9ed51e4ee5806df9de0f938634-HFNTLBQQrRUU.jpg, createdBy=42278230289, createdName=研究牲小F, createdTime=Fri Aug 23 01:24:08 CST 2024, time=2024-08-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2246816, encodeId=4d9e224681683, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：药理学;炎症 经验分享：求问大家这个杂志编辑什么时候上班啊，我10月底投的稿，11.01送审，一审还没回来，等到花儿都谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b26e8424498, createdName=ms9000000976333684, createdTime=Mon Jan 06 11:29:42 CST 2025, time=2025-01-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2261842, encodeId=607c226184268, content=审稿人接受了邀请但迟迟不审稿该怎么办，已经一个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded55595736, createdName=ms4000000082043336, createdTime=Thu Apr 24 12:15:10 CST 2025, time=2025-04-24, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2264698, encodeId=6d1a226469848, content=4月29号提交, 5月12号under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2e26491969, createdName=ms8000000177380007, createdTime=Mon May 12 19:24:02 CST 2025, time=2025-05-12, status=1, ipAttribution=上海)]

2025-06-27 匿名用户

提供系统中要求通讯作者必须提供机构邮箱

4 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2234202, encodeId=87a3223420201, content=9.14 投稿 9.16外审3个审稿人（之前投过主编说按之前3个审稿人意见修改后再投）当天一个审回 10.5另外一个审回还有一个未接收 review completed 10.6 dip 到今天还是dip 不知什么情况有类似这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04fe5219567, createdName=14778916m81暂无昵称, createdTime=Wed Oct 30 23:33:24 CST 2024, time=2024-10-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2271770, encodeId=968c22e177037, content=状态显示tranfer pending是拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9f9768309, createdName=ms1000001928455201, createdTime=Wed Jul 02 19:42:25 CST 2025, time=2025-07-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2271108, encodeId=8a0d22e1108b8, content=投稿系统中要求通讯作者必须提供机构邮箱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Jun 27 14:56:46 CST 2025, time=2025-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2271107, encodeId=ff5e22e110735, content=提供系统中要求通讯作者必须提供机构邮箱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Jun 27 14:56:31 CST 2025, time=2025-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2266799, encodeId=94f92266e99a9, content=审稿速度:3.0 经验分享：审稿建议里面让找更专业的英语编辑，并提供了语言修饰的网址，我需要花钱修饰语言吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce5a2105858, createdName=心血管敏, createdTime=Tue May 27 08:25:11 CST 2025, time=2025-05-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2254478, encodeId=1f0022544e8a7, content=审稿速度:2.0 偏重的研究方向：心血管病 经验分享：二审后dip2周了，接心软编辑，hope, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9oU11do4KdicQ5zeAeucWoJskC9juemF0Skj0W2iauBhSRLRySPPAib72KGiagGT3XXeyeQKlibUJMDBQXykJOngT7A/132, createdBy=1aaf5315474, createdName=Tilen, createdTime=Tue Mar 04 00:30:39 CST 2025, time=2025-03-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2221998, encodeId=85ac2221998e7, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肾脏;药理学 经验分享：5月17日提交，5月20日编辑要求提交WB三次重复结果，当天提交，过了一周送审，6月11日一审结束，两个审稿人提了很多问题，7月15日一审修改返回，7月17日二审开始，7月26日二审结束，一个审稿人要求补实验否则拒收，另外一个审稿人表示没有问题，8月7日二审补实验修改返回，8月9日三审开始，8月15日三审结束，8月16日DIP，8月22日接收，祝各位好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202408/eb5b5a9ed51e4ee5806df9de0f938634-HFNTLBQQrRUU.jpg, createdBy=42278230289, createdName=研究牲小F, createdTime=Fri Aug 23 01:24:08 CST 2024, time=2024-08-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2246816, encodeId=4d9e224681683, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：药理学;炎症 经验分享：求问大家这个杂志编辑什么时候上班啊，我10月底投的稿，11.01送审，一审还没回来，等到花儿都谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b26e8424498, createdName=ms9000000976333684, createdTime=Mon Jan 06 11:29:42 CST 2025, time=2025-01-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2261842, encodeId=607c226184268, content=审稿人接受了邀请但迟迟不审稿该怎么办，已经一个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded55595736, createdName=ms4000000082043336, createdTime=Thu Apr 24 12:15:10 CST 2025, time=2025-04-24, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2264698, encodeId=6d1a226469848, content=4月29号提交, 5月12号under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2e26491969, createdName=ms8000000177380007, createdTime=Mon May 12 19:24:02 CST 2025, time=2025-05-12, status=1, ipAttribution=上海)]

2025-05-27 心血管敏来自北京

审稿速度:3.0
经验分享：审稿建议里面让找更专业的英语编辑，并提供了语言修饰的网址，我需要花钱修饰语言吗？

11 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2234202, encodeId=87a3223420201, content=9.14 投稿 9.16外审3个审稿人（之前投过主编说按之前3个审稿人意见修改后再投）当天一个审回 10.5另外一个审回还有一个未接收 review completed 10.6 dip 到今天还是dip 不知什么情况有类似这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04fe5219567, createdName=14778916m81暂无昵称, createdTime=Wed Oct 30 23:33:24 CST 2024, time=2024-10-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2271770, encodeId=968c22e177037, content=状态显示tranfer pending是拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9f9768309, createdName=ms1000001928455201, createdTime=Wed Jul 02 19:42:25 CST 2025, time=2025-07-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2271108, encodeId=8a0d22e1108b8, content=投稿系统中要求通讯作者必须提供机构邮箱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Jun 27 14:56:46 CST 2025, time=2025-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2271107, encodeId=ff5e22e110735, content=提供系统中要求通讯作者必须提供机构邮箱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Jun 27 14:56:31 CST 2025, time=2025-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2266799, encodeId=94f92266e99a9, content=审稿速度:3.0 经验分享：审稿建议里面让找更专业的英语编辑，并提供了语言修饰的网址，我需要花钱修饰语言吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce5a2105858, createdName=心血管敏, createdTime=Tue May 27 08:25:11 CST 2025, time=2025-05-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2254478, encodeId=1f0022544e8a7, content=审稿速度:2.0 偏重的研究方向：心血管病 经验分享：二审后dip2周了，接心软编辑，hope, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9oU11do4KdicQ5zeAeucWoJskC9juemF0Skj0W2iauBhSRLRySPPAib72KGiagGT3XXeyeQKlibUJMDBQXykJOngT7A/132, createdBy=1aaf5315474, createdName=Tilen, createdTime=Tue Mar 04 00:30:39 CST 2025, time=2025-03-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2221998, encodeId=85ac2221998e7, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肾脏;药理学 经验分享：5月17日提交，5月20日编辑要求提交WB三次重复结果，当天提交，过了一周送审，6月11日一审结束，两个审稿人提了很多问题，7月15日一审修改返回，7月17日二审开始，7月26日二审结束，一个审稿人要求补实验否则拒收，另外一个审稿人表示没有问题，8月7日二审补实验修改返回，8月9日三审开始，8月15日三审结束，8月16日DIP，8月22日接收，祝各位好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202408/eb5b5a9ed51e4ee5806df9de0f938634-HFNTLBQQrRUU.jpg, createdBy=42278230289, createdName=研究牲小F, createdTime=Fri Aug 23 01:24:08 CST 2024, time=2024-08-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2246816, encodeId=4d9e224681683, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：药理学;炎症 经验分享：求问大家这个杂志编辑什么时候上班啊，我10月底投的稿，11.01送审，一审还没回来，等到花儿都谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b26e8424498, createdName=ms9000000976333684, createdTime=Mon Jan 06 11:29:42 CST 2025, time=2025-01-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2261842, encodeId=607c226184268, content=审稿人接受了邀请但迟迟不审稿该怎么办，已经一个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded55595736, createdName=ms4000000082043336, createdTime=Thu Apr 24 12:15:10 CST 2025, time=2025-04-24, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2264698, encodeId=6d1a226469848, content=4月29号提交, 5月12号under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2e26491969, createdName=ms8000000177380007, createdTime=Mon May 12 19:24:02 CST 2025, time=2025-05-12, status=1, ipAttribution=上海)]

2025-03-04 Tilen 来自北京

审稿速度:2.0
偏重的研究方向：心血管病
经验分享：二审后dip2周了，接心软编辑，hope

25 7 举报

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2234202, encodeId=87a3223420201, content=9.14 投稿 9.16外审3个审稿人（之前投过主编说按之前3个审稿人意见修改后再投）当天一个审回 10.5另外一个审回还有一个未接收 review completed 10.6 dip 到今天还是dip 不知什么情况有类似这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04fe5219567, createdName=14778916m81暂无昵称, createdTime=Wed Oct 30 23:33:24 CST 2024, time=2024-10-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2271770, encodeId=968c22e177037, content=状态显示tranfer pending是拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9f9768309, createdName=ms1000001928455201, createdTime=Wed Jul 02 19:42:25 CST 2025, time=2025-07-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2271108, encodeId=8a0d22e1108b8, content=投稿系统中要求通讯作者必须提供机构邮箱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Jun 27 14:56:46 CST 2025, time=2025-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2271107, encodeId=ff5e22e110735, content=提供系统中要求通讯作者必须提供机构邮箱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Jun 27 14:56:31 CST 2025, time=2025-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2266799, encodeId=94f92266e99a9, content=审稿速度:3.0 经验分享：审稿建议里面让找更专业的英语编辑，并提供了语言修饰的网址，我需要花钱修饰语言吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce5a2105858, createdName=心血管敏, createdTime=Tue May 27 08:25:11 CST 2025, time=2025-05-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2254478, encodeId=1f0022544e8a7, content=审稿速度:2.0 偏重的研究方向：心血管病 经验分享：二审后dip2周了，接心软编辑，hope, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9oU11do4KdicQ5zeAeucWoJskC9juemF0Skj0W2iauBhSRLRySPPAib72KGiagGT3XXeyeQKlibUJMDBQXykJOngT7A/132, createdBy=1aaf5315474, createdName=Tilen, createdTime=Tue Mar 04 00:30:39 CST 2025, time=2025-03-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2221998, encodeId=85ac2221998e7, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肾脏;药理学 经验分享：5月17日提交，5月20日编辑要求提交WB三次重复结果，当天提交，过了一周送审，6月11日一审结束，两个审稿人提了很多问题，7月15日一审修改返回，7月17日二审开始，7月26日二审结束，一个审稿人要求补实验否则拒收，另外一个审稿人表示没有问题，8月7日二审补实验修改返回，8月9日三审开始，8月15日三审结束，8月16日DIP，8月22日接收，祝各位好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202408/eb5b5a9ed51e4ee5806df9de0f938634-HFNTLBQQrRUU.jpg, createdBy=42278230289, createdName=研究牲小F, createdTime=Fri Aug 23 01:24:08 CST 2024, time=2024-08-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2246816, encodeId=4d9e224681683, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：药理学;炎症 经验分享：求问大家这个杂志编辑什么时候上班啊，我10月底投的稿，11.01送审，一审还没回来，等到花儿都谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b26e8424498, createdName=ms9000000976333684, createdTime=Mon Jan 06 11:29:42 CST 2025, time=2025-01-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2261842, encodeId=607c226184268, content=审稿人接受了邀请但迟迟不审稿该怎么办，已经一个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded55595736, createdName=ms4000000082043336, createdTime=Thu Apr 24 12:15:10 CST 2025, time=2025-04-24, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2264698, encodeId=6d1a226469848, content=4月29号提交, 5月12号under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2e26491969, createdName=ms8000000177380007, createdTime=Mon May 12 19:24:02 CST 2025, time=2025-05-12, status=1, ipAttribution=上海)]

2024-08-23 研究牲小F 来自甘肃省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：肾脏;药理学
经验分享：5月17日提交，5月20日编辑要求提交WB三次重复结果，当天提交，过了一周送审，6月11日一审结束，两个审稿人提了很多问题，7月15日一审修改返回，7月17日二审开始，7月26日二审结束，一个审稿人要求补实验否则拒收，另外一个审稿人表示没有问题，8月7日二审补实验修改返回，8月9日三审开始，8月15日三审结束，8月16日DIP，8月22日接收，祝各位好运！

72 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2234202, encodeId=87a3223420201, content=9.14 投稿 9.16外审3个审稿人（之前投过主编说按之前3个审稿人意见修改后再投）当天一个审回 10.5另外一个审回还有一个未接收 review completed 10.6 dip 到今天还是dip 不知什么情况有类似这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04fe5219567, createdName=14778916m81暂无昵称, createdTime=Wed Oct 30 23:33:24 CST 2024, time=2024-10-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2271770, encodeId=968c22e177037, content=状态显示tranfer pending是拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9f9768309, createdName=ms1000001928455201, createdTime=Wed Jul 02 19:42:25 CST 2025, time=2025-07-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2271108, encodeId=8a0d22e1108b8, content=投稿系统中要求通讯作者必须提供机构邮箱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Jun 27 14:56:46 CST 2025, time=2025-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2271107, encodeId=ff5e22e110735, content=提供系统中要求通讯作者必须提供机构邮箱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Jun 27 14:56:31 CST 2025, time=2025-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2266799, encodeId=94f92266e99a9, content=审稿速度:3.0 经验分享：审稿建议里面让找更专业的英语编辑，并提供了语言修饰的网址，我需要花钱修饰语言吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce5a2105858, createdName=心血管敏, createdTime=Tue May 27 08:25:11 CST 2025, time=2025-05-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2254478, encodeId=1f0022544e8a7, content=审稿速度:2.0 偏重的研究方向：心血管病 经验分享：二审后dip2周了，接心软编辑，hope, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9oU11do4KdicQ5zeAeucWoJskC9juemF0Skj0W2iauBhSRLRySPPAib72KGiagGT3XXeyeQKlibUJMDBQXykJOngT7A/132, createdBy=1aaf5315474, createdName=Tilen, createdTime=Tue Mar 04 00:30:39 CST 2025, time=2025-03-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2221998, encodeId=85ac2221998e7, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肾脏;药理学 经验分享：5月17日提交，5月20日编辑要求提交WB三次重复结果，当天提交，过了一周送审，6月11日一审结束，两个审稿人提了很多问题，7月15日一审修改返回，7月17日二审开始，7月26日二审结束，一个审稿人要求补实验否则拒收，另外一个审稿人表示没有问题，8月7日二审补实验修改返回，8月9日三审开始，8月15日三审结束，8月16日DIP，8月22日接收，祝各位好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202408/eb5b5a9ed51e4ee5806df9de0f938634-HFNTLBQQrRUU.jpg, createdBy=42278230289, createdName=研究牲小F, createdTime=Fri Aug 23 01:24:08 CST 2024, time=2024-08-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2246816, encodeId=4d9e224681683, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：药理学;炎症 经验分享：求问大家这个杂志编辑什么时候上班啊，我10月底投的稿，11.01送审，一审还没回来，等到花儿都谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b26e8424498, createdName=ms9000000976333684, createdTime=Mon Jan 06 11:29:42 CST 2025, time=2025-01-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2261842, encodeId=607c226184268, content=审稿人接受了邀请但迟迟不审稿该怎么办，已经一个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded55595736, createdName=ms4000000082043336, createdTime=Thu Apr 24 12:15:10 CST 2025, time=2025-04-24, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2264698, encodeId=6d1a226469848, content=4月29号提交, 5月12号under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2e26491969, createdName=ms8000000177380007, createdTime=Mon May 12 19:24:02 CST 2025, time=2025-05-12, status=1, ipAttribution=上海)]

2025-01-06 ms9000000976333684 来自浙江省

审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向：药理学;炎症
经验分享：求问大家这个杂志编辑什么时候上班啊，我10月底投的稿，11.01送审，一审还没回来，等到花儿都谢了

33 13 举报

展开13条回复

[GetPortalCommentsPageByObjectIdResponse(id=2234202, encodeId=87a3223420201, content=9.14 投稿 9.16外审3个审稿人（之前投过主编说按之前3个审稿人意见修改后再投）当天一个审回 10.5另外一个审回还有一个未接收 review completed 10.6 dip 到今天还是dip 不知什么情况有类似这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04fe5219567, createdName=14778916m81暂无昵称, createdTime=Wed Oct 30 23:33:24 CST 2024, time=2024-10-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2271770, encodeId=968c22e177037, content=状态显示tranfer pending是拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9f9768309, createdName=ms1000001928455201, createdTime=Wed Jul 02 19:42:25 CST 2025, time=2025-07-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2271108, encodeId=8a0d22e1108b8, content=投稿系统中要求通讯作者必须提供机构邮箱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Jun 27 14:56:46 CST 2025, time=2025-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2271107, encodeId=ff5e22e110735, content=提供系统中要求通讯作者必须提供机构邮箱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Jun 27 14:56:31 CST 2025, time=2025-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2266799, encodeId=94f92266e99a9, content=审稿速度:3.0 经验分享：审稿建议里面让找更专业的英语编辑，并提供了语言修饰的网址，我需要花钱修饰语言吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce5a2105858, createdName=心血管敏, createdTime=Tue May 27 08:25:11 CST 2025, time=2025-05-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2254478, encodeId=1f0022544e8a7, content=审稿速度:2.0 偏重的研究方向：心血管病 经验分享：二审后dip2周了，接心软编辑，hope, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9oU11do4KdicQ5zeAeucWoJskC9juemF0Skj0W2iauBhSRLRySPPAib72KGiagGT3XXeyeQKlibUJMDBQXykJOngT7A/132, createdBy=1aaf5315474, createdName=Tilen, createdTime=Tue Mar 04 00:30:39 CST 2025, time=2025-03-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2221998, encodeId=85ac2221998e7, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肾脏;药理学 经验分享：5月17日提交，5月20日编辑要求提交WB三次重复结果，当天提交，过了一周送审，6月11日一审结束，两个审稿人提了很多问题，7月15日一审修改返回，7月17日二审开始，7月26日二审结束，一个审稿人要求补实验否则拒收，另外一个审稿人表示没有问题，8月7日二审补实验修改返回，8月9日三审开始，8月15日三审结束，8月16日DIP，8月22日接收，祝各位好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202408/eb5b5a9ed51e4ee5806df9de0f938634-HFNTLBQQrRUU.jpg, createdBy=42278230289, createdName=研究牲小F, createdTime=Fri Aug 23 01:24:08 CST 2024, time=2024-08-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2246816, encodeId=4d9e224681683, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：药理学;炎症 经验分享：求问大家这个杂志编辑什么时候上班啊，我10月底投的稿，11.01送审，一审还没回来，等到花儿都谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b26e8424498, createdName=ms9000000976333684, createdTime=Mon Jan 06 11:29:42 CST 2025, time=2025-01-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2261842, encodeId=607c226184268, content=审稿人接受了邀请但迟迟不审稿该怎么办，已经一个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded55595736, createdName=ms4000000082043336, createdTime=Thu Apr 24 12:15:10 CST 2025, time=2025-04-24, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2264698, encodeId=6d1a226469848, content=4月29号提交, 5月12号under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2e26491969, createdName=ms8000000177380007, createdTime=Mon May 12 19:24:02 CST 2025, time=2025-05-12, status=1, ipAttribution=上海)]

2025-04-24 ms4000000082043336 来自河南省

审稿人接受了邀请但迟迟不审稿该怎么办，已经一个多月了

19 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2234202, encodeId=87a3223420201, content=9.14 投稿 9.16外审3个审稿人（之前投过主编说按之前3个审稿人意见修改后再投）当天一个审回 10.5另外一个审回还有一个未接收 review completed 10.6 dip 到今天还是dip 不知什么情况有类似这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04fe5219567, createdName=14778916m81暂无昵称, createdTime=Wed Oct 30 23:33:24 CST 2024, time=2024-10-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2271770, encodeId=968c22e177037, content=状态显示tranfer pending是拒稿了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9f9768309, createdName=ms1000001928455201, createdTime=Wed Jul 02 19:42:25 CST 2025, time=2025-07-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2271108, encodeId=8a0d22e1108b8, content=投稿系统中要求通讯作者必须提供机构邮箱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Jun 27 14:56:46 CST 2025, time=2025-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2271107, encodeId=ff5e22e110735, content=提供系统中要求通讯作者必须提供机构邮箱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Fri Jun 27 14:56:31 CST 2025, time=2025-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2266799, encodeId=94f92266e99a9, content=审稿速度:3.0 经验分享：审稿建议里面让找更专业的英语编辑，并提供了语言修饰的网址，我需要花钱修饰语言吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce5a2105858, createdName=心血管敏, createdTime=Tue May 27 08:25:11 CST 2025, time=2025-05-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2254478, encodeId=1f0022544e8a7, content=审稿速度:2.0 偏重的研究方向：心血管病 经验分享：二审后dip2周了，接心软编辑，hope, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/9oU11do4KdicQ5zeAeucWoJskC9juemF0Skj0W2iauBhSRLRySPPAib72KGiagGT3XXeyeQKlibUJMDBQXykJOngT7A/132, createdBy=1aaf5315474, createdName=Tilen, createdTime=Tue Mar 04 00:30:39 CST 2025, time=2025-03-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2221998, encodeId=85ac2221998e7, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肾脏;药理学 经验分享：5月17日提交，5月20日编辑要求提交WB三次重复结果，当天提交，过了一周送审，6月11日一审结束，两个审稿人提了很多问题，7月15日一审修改返回，7月17日二审开始，7月26日二审结束，一个审稿人要求补实验否则拒收，另外一个审稿人表示没有问题，8月7日二审补实验修改返回，8月9日三审开始，8月15日三审结束，8月16日DIP，8月22日接收，祝各位好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202408/eb5b5a9ed51e4ee5806df9de0f938634-HFNTLBQQrRUU.jpg, createdBy=42278230289, createdName=研究牲小F, createdTime=Fri Aug 23 01:24:08 CST 2024, time=2024-08-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2246816, encodeId=4d9e224681683, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：药理学;炎症 经验分享：求问大家这个杂志编辑什么时候上班啊，我10月底投的稿，11.01送审，一审还没回来，等到花儿都谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b26e8424498, createdName=ms9000000976333684, createdTime=Mon Jan 06 11:29:42 CST 2025, time=2025-01-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2261842, encodeId=607c226184268, content=审稿人接受了邀请但迟迟不审稿该怎么办，已经一个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded55595736, createdName=ms4000000082043336, createdTime=Thu Apr 24 12:15:10 CST 2025, time=2025-04-24, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2264698, encodeId=6d1a226469848, content=4月29号提交, 5月12号under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2e26491969, createdName=ms8000000177380007, createdTime=Mon May 12 19:24:02 CST 2025, time=2025-05-12, status=1, ipAttribution=上海)]

2025-05-12 ms8000000177380007 来自上海

4月29号提交, 5月12号under review

14 0 举报

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务